SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001618835-22-000110
Filing Date
2022-05-10
Accepted
2022-05-10 17:01:26
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evfm-20220331.htm   iXBRL 10-Q 1495607
2 EX-3.1 evfm-3312022xex31.htm EX-3.1 77989
3 EX-31.1 evfm-3312022xex311.htm EX-31.1 19865
4 EX-31.2 evfm-3312022xex312.htm EX-31.2 19727
5 EX-32.1 evfm-3312022xex321.htm EX-32.1 10940
11 delawarestamp.jpg GRAPHIC 52255
12 stateofdelawarestamp.jpg GRAPHIC 53009
  Complete submission text file 0001618835-22-000110.txt   7975933

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20220331.xsd EX-101.SCH 50843
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evfm-20220331_cal.xml EX-101.CAL 70523
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20220331_def.xml EX-101.DEF 379213
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20220331_lab.xml EX-101.LAB 656689
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20220331_pre.xml EX-101.PRE 457201
61 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20220331_htm.xml XML 1263017
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 22910829
SIC: 2834 Pharmaceutical Preparations